Tavneos (avacopan) is a complement inhibitor used to treat certain rare autoimmune conditions that cause blood vessel inflammation. It's FDA approved for adults with severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Tavneos (avacopan) is taken by mouth as a capsule, usually twice a day with food, and is used along with other treatments like corticosteroids. Common side effects include nausea, headache, and high blood pressure.
Tavneos (avacopan) is a complement inhibitor. It blocks a protein which keeps certain immune cells, called neutrophils, from getting activated and moving to areas where they might cause damage. Though it's not exactly known how Tavneos (avacopan) treats ANCA-associated vasculitis, it's thought to reduce inflammation in your blood vessels.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Yes. The FDA approved Tavneos (avacopan) in October 2021 as an add-on to standard treatment for adults with severe ANCA-associated vasculitis.
Though not a traditional immunosuppressant, Tavneos (avacopan) has immunosuppressive effects. It treats ANCA-associated vasculitis by lowering the activity of specific cells in your immune system.
In clinical studies, some people with ANCA-associated vasculitis started to see an improvement within the first 4 weeks when taking it with standard treatment. But it can take several months to see the full benefits. Talk to your prescriber if you have questions about how well this medication might work for you.
Yes, fatigue (or tiredness) is a common side effect of Tavneos (avacopan). In clinical trials, about 10% of people reported feeling more tired than usual while taking it. If you notice this side effect, talk to your prescriber to see what might be causing it and how to manage it.
Tavneos (avacopan) isn't well studied in pregnant people, so it's unclear if it's completely safe during pregnancy. Animal studies showed mixed results when the medication was used during pregnancy. If you’re pregnant or planning to become pregnant, talk to your OB-GYN provider about the possible risks and benefits of taking this medication.
Tavneos (avacopan) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Tavneos (avacopan) can cause serious liver problems. You'll need regular blood tests to check your liver health before and during treatment to make sure your liver is working as it should. Get medical help right away if you notice yellowing of your skin or eyes, pain in the upper right side of your stomach, unusual tiredness, dark or brown urine, easy bruising or bleeding, or loss of appetite. Your prescriber might stop the medication to help prevent more liver damage.
Tavneos (avacopan) can cause a serious allergic reaction called angioedema, which can involve swelling of the face, lips, tongue, or throat. This can make it hard to breathe or swallow and needs emergency medical care. If you notice these symptoms, stop taking the medication and get help right away.
Tavneos (avacopan) can cause hepatitis B virus (HBV) to reactivate, which means the virus becomes active again in someone who had it in the past, even if it seems gone. This can lead to serious or life-threatening liver problems. Your prescriber will screen you for signs of current or past HBV infection before you start treatment.
If you do have HBV, you’ll be closely monitored during treatment and for 6 months after stopping Tavneos (avacopan). Tell your prescriber right away if you notice yellowing of your skin or eyes, dark urine, tiredness, or pain in the upper right side of your stomach. If HBV reactivation happens, you’ll need to stop Tavneos (avacopan) and begin treatment to protect your liver.
Some people taking Tavneos (avacopan) experienced severe, life-threatening infections. The most common serious infections in clinical studies were pneumonia and urinary tract infections (UTIs). If you get a fever or other signs of infection — like cough, tiredness, body aches, chills, headache, painful urination, or cold sores — contact your prescriber. Depending on how serious the infection is, you might need to stop taking the medication until the infection is under control.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 10mg | 180 capsules | $18,312.64 | $101.74 |
The typical dose is 30 mg (three 10 mg capsules) by mouth twice a day with food.
Your dose might be lower if you take medications that interact with Tavneos (avacopan).